Free Virtual Consultations. Corona Virus Related Cases Click Here.

Man Killed in Crash on Towne Avenue

Victim Dies in Claremont Hit and Run Accident; Driver at Large

Fatal Accident 3

Claremont, CA (January 8, 2020) – A man was killed in a hit and run crash in Claremont. The fatal accident occurred on the morning of January 8 on Towne Avenue.

 A man in his 50s was killed in a hit-and-run crash. Firefighters discovered the victim lying in the street in the 1600 block of Towne Avenue. It is unknown how long the man was at the crash site. He died at the accident. A description of the vehicle and driver were not available. 

Our heartfelt condolences go out to the friends and loved ones of the victim.



December 30, 2019

2 Killed, 2 Injured in Crash at Artesia Boulevard and Vermont Avenue

Speeding Motorist Runs Red Light in Fatal Gardena Accident...

March 31, 2020

3 Killed in Crash on North Highland Avenue

Street Racing Cause of Fatal Los Angeles Accident...

May 21, 2020

Woman Killed in Crash at Woodruff Avenue and Willow Street

Driver Flees Scene of Fatal Long Beach Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.